Kura Oncology, Inc
Price
FilingsNewest: 8-K, Other eventsSep 9 →InsidersNo open-market buys. 7 insiders sold $2.1M, 7 of 28 sales on a 10b5-1 plan.→HoldersBlackRock 11.8%Montanova Capital 9.6%BVF Inc/il 9.5%→PeersClosest companies: NUVB, KOD, ORIC→
From the filings
Figures
- Revenue
- $77.2Mlast 12 months
- Net income
- −$296.8Mlast 12 months
- Operating cash flow
- −$78.0Mlast 12 months
- Cash and equivalents
- $70.2Mat the last balance sheet
- Total debt
- $9.8Mat the last balance sheet
- Shares outstanding
- 89.0M shareson issue